{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:23:02Z","timestamp":1791868982267,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T00:00:00Z","timestamp":1394841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00277-014-2042-z","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T02:02:58Z","timestamp":1395108178000},"page":"1287-1295","source":"Crossref","is-referenced-by-count":42,"title":["Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis"],"prefix":"10.1007","volume":"93","author":[{"given":"Stefan","family":"W\u00f6hrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kiesewetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Troch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius E.","family":"Mayerhoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,15]]},"reference":[{"key":"2042_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/modpathol.3880035","volume":"13","author":"NL Harris","year":"2000","unstructured":"Harris NL, Jaffe ES, Diebold J et al (2000) The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 13:193\u2013207","journal-title":"Mod Pathol"},{"key":"2042_CR2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2141.2011.08841.x","volume":"155","author":"U Novak","year":"2011","unstructured":"Novak U, Basso K, Pasqualucci L et al (2011) Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells. Br J Haematol 155:362\u2013365","journal-title":"Br J Haematol"},{"key":"2042_CR3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0140-6736(93)91408-E","volume":"342","author":"T Hussell","year":"1993","unstructured":"Hussell T, Isaacson PG, Crabtree JE et al (1993) The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342:571\u2013574","journal-title":"Lancet"},{"key":"2042_CR4","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","volume":"101","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Pedrinis E et al (2003) Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101:2489\u20132495","journal-title":"Blood"},{"key":"2042_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2004.04993.x","volume":"126","author":"A Ambrosetti","year":"2004","unstructured":"Ambrosetti A, Zanotti R, Pattaro C et al (2004) Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol 126:43\u201349","journal-title":"Br J Haematol"},{"key":"2042_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/art.22476","volume":"57","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, la Civita L, de Vita S et al (2007) Characterization of B cell lymphoma in patients with Sjogren\u2019s syndrome and hepatitis C virus infection. Arthritis Rheum 57:161\u2013170","journal-title":"Arthritis Rheum"},{"key":"2042_CR7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2008.03.031","volume":"49","author":"M Libra","year":"2008","unstructured":"Libra M, Gloghini A, Malaponte G et al (2008) Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas. J Hepatol 49:170\u2013174","journal-title":"J Hepatol"},{"key":"2042_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","volume":"342","author":"AC Wotherspoon","year":"1993","unstructured":"Wotherspoon AC, Doglioni C, Diss TC et al (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575\u2013577","journal-title":"Lancet"},{"key":"2042_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/10428199709050889","volume":"26","author":"G Pinotti","year":"1997","unstructured":"Pinotti G, Zucca E, Roggero E et al (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 26:527\u2013537","journal-title":"Leuk Lymphoma"},{"key":"2042_CR10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","volume":"60","author":"A Ruskone-Fourmestraux","year":"2011","unstructured":"Ruskone-Fourmestraux A, Fischbach W, Aleman BM et al (2011) EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60:747\u2013758","journal-title":"Gut"},{"key":"2042_CR11","doi-asserted-by":"crossref","first-page":"v175","DOI":"10.1093\/annonc\/mdq182","volume":"Suppl 5","author":"E Zucca","year":"2010","unstructured":"Zucca E, Dreyling M (2010) Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Suppl 5:v175\u2013v176","journal-title":"Ann Oncol"},{"key":"2042_CR12","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1200\/JCO.2006.06.0723","volume":"24","author":"M Raderer","year":"2006","unstructured":"Raderer M, Wohrer S, Streubel B et al (2006) Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24:3136\u20133141","journal-title":"J Clin Oncol"},{"key":"2042_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.11835","volume":"93","author":"JP Boer de","year":"2008","unstructured":"de Boer JP, Hiddink RF, Raderer M et al (2008) Dissemination patterns in non-gastric MALT lymphoma. Haematologica 93:201\u2013206","journal-title":"Haematologica"},{"key":"2042_CR14","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","volume":"116","author":"JS Goda","year":"2010","unstructured":"Goda JS, Gospodarowicz M, Pintilie M et al (2010) Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 116:3815\u20133824","journal-title":"Cancer"},{"key":"2042_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2012.065995","volume":"98","author":"B Kiesewetter","year":"2013","unstructured":"Kiesewetter B, Troch M, Dolak W et al (2013) A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma). Haematologica 98:353\u2013356","journal-title":"Haematologica"},{"key":"2042_CR16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11899-011-0095-9","volume":"6","author":"M Troch","year":"2011","unstructured":"Troch M, Kiesewetter B, Raderer M (2011) Recent developments in nongastric mucosa-associated lymphoid tissue lymphoma. Curr Hematol Malig Rep 6:216\u2013221","journal-title":"Curr Hematol Malig Rep"},{"key":"2042_CR17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3324\/haematol.2008.001537","volume":"94","author":"M Troch","year":"2009","unstructured":"Troch M, Jonak C, Mullauer L et al (2009) A phase II study of bortezomib in patients with MALT lymphoma. Haematologica 94:738\u2013742","journal-title":"Haematologica"},{"key":"2042_CR18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000098555","volume":"70","author":"M Raderer","year":"2006","unstructured":"Raderer M, Wohrer S, Streubel B et al (2006) Activity of rituximab plus cyclophosphamide, doxorubicin\/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma. Oncology 70:411\u2013417","journal-title":"Oncology"},{"key":"2042_CR19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3324\/haematol.2012.072587","volume":"98","author":"M Troch","year":"2013","unstructured":"Troch M, Kiesewetter B, Willenbacher W et al (2013) Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie. Haematologica 98:264\u2013268","journal-title":"Haematologica"},{"key":"2042_CR20","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1002\/cncr.24605","volume":"115","author":"A Salar","year":"2009","unstructured":"Salar A, Domingo-Domenech E, Estany C et al (2009) Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer 115:5210\u20135217","journal-title":"Cancer"},{"key":"2042_CR21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1200\/JCO.2005.02.9025","volume":"24","author":"B Grunberger","year":"2006","unstructured":"Grunberger B, Wohrer S, Streubel B et al (2006) Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol 24:1370\u20131375","journal-title":"J Clin Oncol"},{"key":"2042_CR22","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/annonc\/mdg492","volume":"14","author":"S Wohrer","year":"2003","unstructured":"Wohrer S, Drach J, Hejna M et al (2003) Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol 14:1758\u20131761","journal-title":"Ann Oncol"},{"key":"2042_CR23","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1200\/JCO.2002.05.117","volume":"20","author":"G Jager","year":"2002","unstructured":"Jager G, Neumeister P, Brezinschek R et al (2002) Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 20:3872\u20133877","journal-title":"J Clin Oncol"},{"key":"2042_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MO:22:1:057","volume":"22","author":"A Aviles","year":"2005","unstructured":"Aviles A, Nambo MJ, Neri N et al (2005) Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Med Oncol 22:57\u201362","journal-title":"Med Oncol"},{"key":"2042_CR25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"2042_CR26","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K et al (1971) Report of the Committee on Hodgkin\u2019s Disease Staging Classification. Cancer Res 31:1860\u20131861","journal-title":"Cancer Res"},{"key":"2042_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.53.1.34","volume":"53","author":"W Fischbach","year":"2004","unstructured":"Fischbach W, Goebeler-Kolve ME, Dragosics B et al (2004) Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53:34\u201337","journal-title":"Gut"},{"key":"2042_CR28","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-Celigny","year":"2004","unstructured":"Solal-Celigny P, Roy P, Colombat P et al (2004) Follicular lymphoma international prognostic index. Blood 104:1258\u20131265","journal-title":"Blood"},{"key":"2042_CR29","doi-asserted-by":"crossref","unstructured":"(1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med 329:987\u2013994","DOI":"10.1056\/NEJM199309303291402"},{"key":"2042_CR30","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG et al (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412\u20133420","journal-title":"J Clin Oncol"},{"key":"2042_CR31","doi-asserted-by":"crossref","unstructured":"Wohrer S, Troch M, Streubel B, et al (2007) Pathology and clinical course of MALT lymphoma with plasmacytic differentiation. Ann Oncol 18:2020\u20132024","DOI":"10.1093\/annonc\/mdm375"},{"key":"2042_CR32","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1158\/1078-0432.CCR-04-0803","volume":"10","author":"S Wohrer","year":"2004","unstructured":"Wohrer S, Streubel B, Bartsch R et al (2004) Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res 10:7179\u20137181","journal-title":"Clin Cancer Res"},{"key":"2042_CR33","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/sj.leu.2404782","volume":"21","author":"S Wohrer","year":"2007","unstructured":"Wohrer S, Troch M, Streubel B et al (2007) MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course. Leukemia 21:1812\u20131818","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2042-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2042-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2042-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:49:50Z","timestamp":1559022590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2042-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,15]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2042"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2042-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,15]]}}}